Talk:Α-Ethyltryptamine

Pharmacology Low‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
Low	This article has been rated as Low-importance on the project's importance scale.

Psychoactive and Recreational Drugs Stub‑class (defunct)

	This article is within the scope of WikiProject Psychoactive and Recreational Drugs, a project which is currently considered to be defunct.Psychoactive and Recreational DrugsWikipedia:WikiProject Psychoactive and Recreational DrugsTemplate:WikiProject Psychoactive and Recreational DrugsPsychoactive and Recreational Drugs articles
Stub	This article has been given a rating which conflicts with the project-independent quality rating in the banner shell. Please resolve this conflict if possible.

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Α-Ethyltryptamine.

PubMed provides review articles from the past five years (limit to free review articles)
The TRIP database provides clinical publications about evidence-based medicine.
Other potential sources include: Centre for Reviews and Dissemination and CDC

The source regarding neurotixicity states its as potent a neurotoxin as mdma. Which is almost nothing. Rewrite it to clear this up... — Preceding unsigned comment added by 174.253.16.19 (talk) 09:56, 17 July 2011 (UTC)[reply]

Talk:Α-Ethyltryptamine

Navigation menu

Search